Drug Research
X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range
X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its US-based...
News
Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation
Samsung Bioepis Co., Ltd. announced the opening of its new headquarters in Korea’s ‘Bio Cluster’ of Songdo, located in the Incheon Free Economic Zone...
News
AbbVie’s Rinvoq receives European approval to treat active psoriatic arthritis
AbbVie announced that the EC has approved Rinvoq (upadacitinib, 15 mg), an oral, once daily selective and reversible JAK inhibitor for the treatment of...
News
Saudi Arabia to get three million AstraZeneca shots from India
The Serum Institute of India (SII) will supply Saudi Arabia with 3 million AstraZeneca COVID-19 vaccine doses priced at $5.25 each in about a...
News
MedPharm Former CSO Marc Brown Champions Company Innovation in New Role
MedPharm Ltd, the world’s leading contract service provider of contract topical and transdermal product design and formulation development services, has launched its Scientific Advisory...
News
Roche and Sysmex renew partnership to deliver haematology testing solutions
Roche announced that, on 14 December, 2020, it signed a Global Business Partnership Agreement (GBP) with Sysmex. Under this new framework, the parties renewed...
News
AstraZeneca’s Calquence gets Japanese approval to treat adult patients with relapsed/refractory CLL
AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with relapsed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read